Substandard drugs: a potential crisis for public health
暂无分享,去创建一个
[1] K. Ofori-Kwakye,et al. Substandard artemisinin-based antimalarial medicines in licensed retail pharmaceutical outlets in Ghana. , 2012, Journal of vector borne diseases.
[2] Taryn Vian,et al. Review of corruption in the health sector: theory, methods and interventions. , 2007, Health policy and planning.
[3] P. Newton,et al. The WWARN Antimalarial Quality Surveyor , 2012, Pathogens and global health.
[4] Paul N. Newton,et al. The Global Threat of Counterfeit Drugs: Why Industry and Governments Must Communicate the Dangers , 2005, PLoS Medicine.
[5] A. Attaran,et al. Pilot Study of Essential Drug Quality in Two Major Cities in India , 2009, PloS one.
[6] O. Onwujekwe,et al. Quality of anti-malarial drugs provided by public and private healthcare providers in south-east Nigeria , 2009, Malaria Journal.
[7] Mark Davison,et al. Pharmaceutical Anti-Counterfeiting: Combating the Real Danger from Fake Drugs , 2011 .
[8] G. Rassool. Substandard and counterfeit medicines. , 2004, Journal of advanced nursing.
[9] A. Hussain,et al. OFLOXACIN: LABORATORY EVALUATION OF THE ANTIBACTERIAL ACTIVITY OF 34 BRANDS REPRESENTING 31 MANUFACTURERS AVAILABLE IN PAKISTAN , 2004 .
[10] Sergei G. Kazarian,et al. Assessment of hand-held Raman instrumentation for in situ screening for potentially counterfeit artesunate antimalarial tablets by FT-Raman spectroscopy and direct ionization mass spectrometry. , 2008, Analytica chimica acta.
[11] M. Fukuda,et al. Evidence of artemisinin-resistant malaria in western Cambodia. , 2008, The New England journal of medicine.
[12] Facundo M Fernandez,et al. Detecting counterfeit antimalarial tablets by near-infrared spectroscopy. , 2008, Journal of pharmaceutical and biomedical analysis.
[13] C. Bunce,et al. Variability in the content of Indian generic ciprofloxacin eye drops , 2005, British Journal of Ophthalmology.
[14] M. Arduino,et al. Multistate outbreak of toxic anterior segment syndrome, 2005 , 2008, Journal of cataract and refractive surgery.
[15] C Michael Stein,et al. “Inactive” excipients such as Cremophor can affect in vivo drug disposition , 2003, Clinical pharmacology and therapeutics.
[16] R. Maude,et al. Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance , 2009, Malaria Journal.
[17] An Herbal Remedy for Impotence: More Than Was Bargained For , 2006, Journal of clinical pharmacology.
[18] O. Shakoor,et al. Pharmacopoeial quality of drugs supplied by Nigerian pharmacies , 2001, The Lancet.
[19] H. Goubran. Failure of a non-authorized copy product to maintain response achieved with imatinib in a patient with chronic phase chronic myeloid leukemia: a case report , 2009, Journal of medical case reports.
[20] S. P. Kachur,et al. A Nationwide Survey of the Quality of Antimalarials in Retail Outlets in Tanzania , 2008, PloS one.
[21] S. Kyriacos,et al. Quality of amoxicillin formulations in some Arab countries , 2008, Journal of clinical pharmacy and therapeutics.
[22] L. Basco,et al. Molecular epidemiology of malaria in Cameroon. XIX. Quality of antimalarial drugs used for self-medication. , 2004, The American journal of tropical medicine and hygiene.
[23] S. Arver,et al. Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks , 2010, International journal of clinical practice.
[24] M. Mcgeehin,et al. Medication-associated diethylene glycol mass poisoning: A review and discussion on the origin of contamination , 2009, Journal of public health policy.
[25] Multisource (generic) pharmaceutical products: guidelines on registration requirements to establish interchangeability , 2006 .
[26] M. Arduino,et al. Multistate outbreak of Serratia marcescens bloodstream infections caused by contamination of prefilled heparin and isotonic sodium chloride solution syringes. , 2009, Archives of internal medicine.
[27] P. Gjersvik,et al. [Biosimilar medicines]. , 2015, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.
[28] A. S. Rouf,et al. Report: in vitro dissolution studies of different brands of sustained release diclofenac sodium matrix tablet available in Bangladesh. , 2008, Pakistan journal of pharmaceutical sciences.
[29] D. G. Angeli,et al. Quality and Stability of Ramipril Generics/Copies versus Reference Ramipril (Tritace®) , 2009, Clinical drug investigation.
[30] F. Nosten,et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study , 2012, The Lancet.
[31] G. Kokwaro,et al. Antimalarial drug quality in Africa , 2007, Journal of clinical pharmacy and therapeutics.
[32] J. Remon,et al. In vitro evaluation of the quality of essential drugs on the Tanzanian market , 2002, Tropical medicine & international health : TM & IH.
[33] P. Newton,et al. Manslaughter by Fake Artesunate in Asia—Will Africa Be Next? , 2006, PLoS medicine.
[34] R. González-Ramírez,et al. Comparison of dissolution properties of 2 enteric-coated formulations containing mycophenolate sodium: Myfortic vs Femulan. , 2010, Transplantation Proceedings.
[35] C. Nightingale. A Survey of the Quality of Generic Clarithromycin Products from 18 Countries , 2005 .
[36] R. Snow,et al. The quality of sulphadoxine‐pyrimethamine and amodiaquine products in the Kenyan retail sector , 2005, Journal of clinical pharmacy and therapeutics.
[37] Shiji Zhou,et al. Establishment of a Fast Chemical Identification System for screening of counterfeit drugs of macrolide antibiotics. , 2006, Journal of pharmaceutical and biomedical analysis.
[38] Emad Samuel. Eye on the ball , 1998 .
[39] K. Na-Bangchang,et al. Strengthening of national capacity in implementation of antimalarial drug quality assurance in Thailand. , 2006 .
[40] A S Kenyon,et al. Drug quality screening in developing countries: establishment of an appropriate laboratory in Swaziland. , 1994, Bulletin of the World Health Organization.
[41] P. Newton,et al. How to achieve international action on falsified and substandard medicines , 2012, BMJ : British Medical Journal.
[42] K. Thimasarn,et al. Strengthening of national capacity in implementation of antimalarial drug quality assurance in Thailand. , 2006, The Southeast Asian journal of tropical medicine and public health.
[43] P M Wax,et al. Elixirs, Diluents, and the Passage of the 1938 Federal Food, Drug and Cosmetic Act , 1995, Annals of Internal Medicine.
[44] B. Conway,et al. Pharmaceutical Quality of Ceftriaxone Generic Drug Products Compared with Rocephin® , 2003, Journal of chemotherapy.
[45] Patrick Lukulay,et al. Assessment of the performance of a handheld Raman device for potential use as a screening tool in evaluating medicines quality. , 2013, Journal of pharmaceutical and biomedical analysis.
[46] R. Bate. The Deadly World of Falsified and Sub-Standard Medicine , 2012 .
[47] H. McIlleron,et al. Recent bioequivalence studies on fixed-dose combination anti-tuberculosis drug formulations available on the global market. , 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[48] Michael A. Veronin,et al. Comparison of Simvastatin Tablets from the US and International Markets Obtained via the Internet , 2008, The Annals of pharmacotherapy.
[49] G. A. Pianetti,et al. Quality of essential drugs in tropical countries: evaluation of antimalarial drugs in the Brazilian Health System. , 2011, Revista da Sociedade Brasileira de Medicina Tropical.
[50] Kimberly Hess,et al. Assessing Website Pharmacy Drug Quality: Safer Than You Think? , 2010, PloS one.
[51] A. Y. Itah,et al. Bacteriological quality of some pharmaceutical products marketed by drug vendors in Uyo, Nigeria. , 2005, African journal of health sciences.
[52] M. Mayxay,et al. Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross‐sectional survey on the prevalence of fake antimalarials , 2004, Tropical medicine & international health : TM & IH.
[53] J. Plaizier-Vercammen,et al. Quality control of active ingredients in artemisinin‐derivative antimalarials within Kenya and DR Congo , 2006, Tropical medicine & international health : TM & IH.
[54] M. Kainer,et al. Fungal infections associated with contaminated methylprednisolone in Tennessee. , 2012, The New England journal of medicine.
[55] Julian C. Smith,et al. Are generic formulations of carvedilol of inferior pharmaceutical quality compared with the branded formulation?* , 2006, Current medical research and opinion.
[56] N. Homedes,et al. Multisource drug policies in Latin America: survey of 10 countries. , 2005, Bulletin of the World Health Organization.
[57] W. Temple,et al. Diethylene glycol poisoning , 2009, Clinical toxicology.
[58] J. Riviere,et al. Ensuring Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad , 2013 .
[59] D. Socheat,et al. Counterfeit and substandard antimalarial drugs in Cambodia. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[60] H. Petersen,et al. Pharmacokinetic and technical comparison of Sandostatin® LAR® and other formulations of long-acting octreotide , 2011, BMC Research Notes.
[61] M. Scheld,et al. Comparative analysis of the activity and content of different streptokinase preparations. , 2005, European heart journal.
[62] Paul N. Newton,et al. Poor quality drugs: grand challenges in high throughput detection, countrywide sampling, and forensics in developing countries. , 2011, The Analyst.
[63] 65th World Health Assembly closes with new global health measures. , 2012, Central European journal of public health.
[64] Christina Y Hampton,et al. A stratified random survey of the proportion of poor quality oral artesunate sold at medicine outlets in the Lao PDR – implications for therapeutic failure and drug resistance , 2009, Malaria Journal.
[65] W. Kaplan,et al. Paying for pharmaceutical registration in developing countries. , 2003, Health policy and planning.
[66] Gerd Mikus,et al. Pharmacokinetic and pharmaceutic interaction between digoxin and Cremophor RH40 , 2003, Clinical pharmacology and therapeutics.
[67] B. Lindgren,et al. The quality of drugs in private pharmacies in Lao PDR: a repeat study in 1997 and 1999 , 2004, Pharmacy World and Science.
[68] N. Undre,et al. Physiochemical properties of generic formulations of tacrolimus in Mexico. , 2008, Transplantation proceedings.
[69] S. Singh,et al. A pilot stability study on four-drug fixed-dose combination anti-tuberculosis products. , 2003, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[70] Access to HIV/AIDS drugs and diagnostics of acceptable quality. Pilot procurement, quality, and sourcing project. , 2002, IAPAC monthly.
[71] M. Issack. Substandard drugs , 2001, The Lancet.
[72] M. Massi-Benedetti,et al. Quality and behavior of glimepiride generics versus amaryl under stressed conditions. , 2007, Diabetes technology & therapeutics.
[73] I. Gyssens,et al. Cross-sectional study of availability and pharmaceutical quality of antibiotics requested with or without prescription (Over The Counter) in Surabaya, Indonesia , 2010, BMC infectious diseases.
[74] J. Samet,et al. Food and Drug Administration , 2007, BMJ : British Medical Journal.
[75] Thomas Layloff,et al. The use of Minilabs to improve the testing capacity of regulatory authorities in resource limited settings: Tanzanian experience. , 2008, Health policy.
[76] F. Ballereau,et al. Quality Control of Antibiotics Before the Implementation of an STD Program in Northern Myanmar , 2002, Sexually transmitted diseases.
[77] T. Kenyon,et al. Substandard tuberculosis drugs on the global market and their simple detection. , 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[78] M. Malet‐Martino,et al. Generic ciprofloxacin tablets contain the stated amount of drug and different impurity profiles: A 19F, 1H and DOSY NMR analysis. , 2007, Journal of pharmaceutical and biomedical analysis.
[79] Robert Langer,et al. Outbreak of adverse reactions associated with contaminated heparin. , 2008, The New England journal of medicine.
[80] J. Remon,et al. Influence of tropical climate conditions on the quality of antihypertensive drugs from Rwandan pharmacies. , 2009, The American journal of tropical medicine and hygiene.
[81] R. Tahar,et al. Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children. , 2007, Acta tropica.
[82] P. Newton,et al. Poor quality vital anti-malarials in Africa - an urgent neglected public health priority , 2011, Malaria Journal.
[83] M. Moshi,et al. Comparative Bioavailability of Oral Sugar-Coated and Plain Formulation of Chloroquine Phosphate Marketed in Tanzania , 2002, Tropical doctor.
[84] D. F. James,et al. Generic versus brand-name North American topical glaucoma drops. , 2012, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
[85] S. Colson. Agence nationale de sécurité du médicament et des produits de santé , 2013 .
[86] Matthew E Falagas,et al. Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence. , 2007, The Journal of antimicrobial chemotherapy.
[87] Olike Chinwendu. The fight against fake drugs by NAFDAC in Nigeria , 2010 .
[88] J. Kohler,et al. Transparency in Nigeria's public pharmaceutical sector: perceptions from policy makers , 2009, Globalization and health.
[89] J. Hoogmartens,et al. Analysis of purity in 19 drug product tablets containing clopidogrel: 18 copies versus the original brand. , 2004, Journal of pharmaceutical and biomedical analysis.
[90] M. Hosseinipour,et al. Pharmacokinetic comparison of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian adults , 2007, AIDS.
[91] P. Newton,et al. Impaired clinical response in a patient with uncomplicated falciparum malaria who received poor-quality and underdosed intramuscular artemether. , 2008, The American journal of tropical medicine and hygiene.
[92] H. Lehr,et al. Particulate matter contamination of intravenous antibiotics aggravates loss of functional capillary density in postischemic striated muscle. , 2002, American journal of respiratory and critical care medicine.
[93] Michael A. Veronin,et al. Packaging and Labeling of Pharmaceutical Products Obtained from the Internet , 2011, Journal of medical Internet research.
[94] M. Rowland,et al. Epidemic of Plasmodium falciparum Malaria Involving Substandard Antimalarial Drugs, Pakistan, 2003 , 2009, Emerging infectious diseases.
[95] Rassool Gh,et al. Substandard and counterfeit medicines. , 2004 .
[96] J. Vial,et al. Pharmaceutical quality of docetaxel generics versus originator drug product: a comparative analysis. , 2008, Current medical research and opinion.
[97] A. Wertheimer,et al. Safeguarding against substandard/counterfeit drugs: mitigating a macroeconomic pandemic. , 2009, Research in social & administrative pharmacy : RSAP.
[98] M. Falagas,et al. Incidence of postoperative infections in patients undergoing coronary artery bypass grafting surgery receiving antimicrobial prophylaxis with original and generic cefuroxime. , 2008, The Journal of infection.
[99] L. Valvo,et al. Medicines informal market in Congo, Burundi and Angola: counterfeit and sub-standard antimalarials , 2007, Malaria Journal.
[100] Z. Chouffai. Hematologic Relapse after 2 Years on a Non-Authorized Copy Version of Imatinib in a Patient with Chronic Myeloid Leukemia in Chronic Phase: A Case Report , 2010, Case Reports in Oncology.
[101] P. Taylor,et al. Pharmaceutical quality of generic isotretinoin products, compared with Roaccutane , 2006, Current medical research and opinion.
[102] G. Tomson,et al. Evaluation of the quality of amodiaquine and sulphadoxine/pyrimethamine tablets sold by private wholesale pharmacies in Dar Es Salaam Tanzania , 2003, Journal of clinical pharmacy and therapeutics.
[103] L. Gostin,et al. Countering the Problem of Falsified and Substandard Drugs , 2013 .
[104] A. Attaran,et al. Antimalarial Drug Quality in the Most Severely Malarious Parts of Africa – A Six Country Study , 2008, PloS one.
[105] O. Müller,et al. Substandard anti-malarial drugs in Burkina Faso , 2008, Malaria Journal.
[106] J. Caminero. Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[107] A. Raufu. Nigeria Leads Fight against "Killer" Counterfeit Drugs , 2006 .
[108] Pharmaceutical Quality of Nine Generic Orlistat Products Compared with Xenical® , 2010, Obesity Facts.
[109] P. Newton,et al. Murder by fake drugs , 2002, British medical journal.
[110] Lalita K. Gardner,et al. Benzene production from decarboxylation of benzoic acid in the presence of ascorbic acid and a transition-metal catalyst , 1993 .
[111] S. Geerts,et al. Anthelmintic resistance in human helminths: a review , 2001, Tropical medicine & international health : TM & IH.
[112] K. Kimura,et al. High failure rate of the dissolution tests for 500‐mg amoxicillin capsules sold in Cambodia: is it because of the product or the test method? , 2010, Tropical medicine & international health : TM & IH.
[113] A. Hirschfelder. THE UNITED STATES PHARMACOPEIAL CONVENTION , 1930 .
[114] B. Alisjahbana,et al. Bioavailability of rifampicin in Indonesian subjects: a comparison of different local drug manufacturers. , 2004, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[115] C. Chaccour,et al. Travel and fake artesunate: a risky business , 2012, The Lancet.
[116] M. Mattar. Failure of copy Imatib (CIPLA, India) to maintain hematologic and cytogenetic responses in chronic myeloid leukemia in chronic phase , 2010, International journal of hematology.
[117] S. Solomon,et al. Antibiotic resistance threats in the United States: stepping back from the brink. , 2014, American family physician.
[118] F. Jansen. The pharmaceutical death-ride of dihydroartemisinin , 2010, Malaria Journal.
[119] N. Ford,et al. Substandard medicines in resource‐poor settings: a problem that can no longer be ignored , 2008, Tropical medicine & international health : TM & IH.
[120] A. Harris,et al. Generic medications in ophthalmology , 2012, British Journal of Ophthalmology.
[121] M. Green,et al. Authentication of artemether, artesunate and dihydroartemisinin antimalarial tablets using a simple colorimetric method , 2001, Tropical medicine & international health : TM & IH.
[122] H. Atta,et al. The quality of antimalarials available in Yemen , 2005, Malaria Journal.
[123] Shereen A. Elshazly,et al. Changing therapy from Glivec® to a "copy" imatinib results in a worsening of chronic myeloid leukemia disease status: two case reports , 2009, Cases journal.